MICROBOT MEDICAL INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
MICROBOT MEDICAL INC. (MBOT) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $433.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-11
- MICROBOT MEDICAL INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $433.00K, a 82.70% increase year-over-year.
- MICROBOT MEDICAL INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $222.00K, a 13.28% decline year-over-year.
- MICROBOT MEDICAL INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $328.00K, a 15.90% increase year-over-year.
- MICROBOT MEDICAL INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $237.00K, a 28.40% decline year-over-year.
- MICROBOT MEDICAL INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $1.06M, a 25.82% decline from fiscal 2024.
- MICROBOT MEDICAL INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $1.43M, a 2.22% increase from fiscal 2023.
- MICROBOT MEDICAL INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $1.39M, a 20.43% decline from fiscal 2022.
- MICROBOT MEDICAL INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $1.75M, a 26.41% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $433.00K 10-Q · filed 2026-08-11 | $655.00K derived: sum of 2 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $222.00K 10-Q · filed 2026-08-11 | |||||
| 2025-12-31 | $1.06M 10-K · filed 2026-03-26 | |||||
| 2025-09-30 | $328.00K 10-Q · filed 2025-11-12 | $565.00K derived: sum of 2 quarters · filed 2026-08-11 | $821.00K derived: sum of 3 quarters · filed 2026-08-11 | |||
| 2025-06-30 | $237.00K 10-Q · filed 2026-08-11 | $493.00K derived: sum of 2 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $256.00K 10-Q · filed 2026-08-11 | |||||
| 2024-12-31 | $1.43M 10-K · filed 2026-03-26 | |||||
| 2024-09-30 | $283.00K 10-Q · filed 2025-11-12 | $614.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.14M derived: sum of 3 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $331.00K 10-Q · filed 2025-11-12 | $860.00K derived: sum of 2 quarters · filed 2025-11-12 | ||||
| 2024-03-31 | $529.00K 10-Q · filed 2025-11-12 | |||||
| 2023-12-31 | $1.39M 10-K · filed 2025-03-25 | |||||
| 2023-09-30 | $336.00K 10-Q · filed 2024-11-13 | $685.00K derived: sum of 2 quarters · filed 2024-11-13 | $1.10M derived: sum of 3 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $349.00K 10-Q · filed 2024-11-13 | $761.00K derived: sum of 2 quarters · filed 2024-11-13 | ||||
| 2023-03-31 | $412.00K 10-Q · filed 2024-11-13 | |||||
| 2022-12-31 | $1.75M 10-K · filed 2024-03-27 | |||||
| 2022-09-30 | $461.00K 10-Q · filed 2023-11-14 | $893.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.32M derived: sum of 3 quarters · filed 2023-11-14 | $1.69M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $432.00K 10-Q · filed 2023-11-14 | $861.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.23M derived: sum of 3 quarters · filed 2023-11-14 | $1.54M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-03-31 | $429.00K 10-Q · filed 2023-11-14 | $799.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.11M derived: sum of 3 quarters · filed 2023-11-14 | $1.41M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2021-12-31 | $370.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $677.00K derived: sum of 2 quarters · filed 2023-03-31 | $976.00K derived: sum of 3 quarters · filed 2023-03-31 | $1.39M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $307.00K 10-Q · filed 2022-11-14 | $606.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.02M 10-Q · filed 2021-11-15 | $1.49M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $299.00K 10-Q · filed 2022-11-14 | $709.00K 10-Q · filed 2021-08-16 | $1.18M derived: sum of 3 quarters · filed 2022-11-14 | $1.74M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-03-31 | $410.00K 10-Q · filed 2022-11-14 | $879.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.44M derived: sum of 3 quarters · filed 2022-11-14 | $2.00M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2020-12-31 | $469.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.03M derived: sum of 2 quarters · filed 2022-03-31 | $1.59M derived: sum of 3 quarters · filed 2022-03-31 | $1.94M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $559.00K 10-Q · filed 2021-11-15 | $1.13M derived: sum of 2 quarters · filed 2021-11-15 | $1.47M 10-Q · filed 2021-11-15 | $1.66M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $566.00K 10-Q · filed 2021-08-16 | $909.00K 10-Q · filed 2021-08-16 | $1.10M derived: sum of 3 quarters · filed 2021-08-16 | $1.40M derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $343.00K 10-Q · filed 2021-05-17 | $536.00K derived: sum of 2 quarters · filed 2021-05-17 | $832.00K derived: sum of 3 quarters · filed 2021-05-17 | $1.13M derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $489.00K derived: sum of 2 quarters · filed 2021-03-31 | $784.00K derived: sum of 3 quarters · filed 2021-03-31 | $1.10M 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $296.00K 10-Q · filed 2020-11-16 | $591.00K derived: sum of 2 quarters · filed 2020-11-16 | $906.00K 10-Q · filed 2020-11-16 | $1.17M derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | $295.00K 10-Q · filed 2020-08-14 | $610.00K 10-Q · filed 2020-08-14 | $870.00K derived: sum of 3 quarters · filed 2020-08-14 | $1.19M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $315.00K 10-Q · filed 2020-05-15 | $575.00K derived: sum of 2 quarters · filed 2020-05-15 | $892.00K derived: sum of 3 quarters · filed 2020-05-15 | $1.30M derived: sum of 4 quarters · filed 2020-05-15 | ||
| 2018-12-31 | $260.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-14 | $577.00K derived: sum of 2 quarters · filed 2020-04-14 | $983.00K derived: sum of 3 quarters · filed 2020-04-14 | $1.40M 10-K · filed 2020-04-14 | ||
| 2018-09-30 | $317.00K 10-Q · filed 2019-11-14 | $723.00K derived: sum of 2 quarters · filed 2019-11-14 | $1.14M 10-Q · filed 2019-11-14 | $1.44M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | $406.00K 10-Q · filed 2019-08-14 | $822.00K 10-Q · filed 2019-08-14 | $1.13M derived: sum of 3 quarters · filed 2019-08-14 | $1.15M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $416.00K 10-Q · filed 2019-05-15 | $719.00K derived: sum of 2 quarters · filed 2019-05-15 | $741.00K derived: sum of 3 quarters · filed 2019-05-15 | |||
| 2017-12-31 | $303.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $325.00K derived: sum of 2 quarters · filed 2019-04-01 | $479.00K 10-K · filed 2019-04-01 | |||
| 2017-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $176.00K 10-Q · filed 2017-11-14 | ||||
| 2017-06-30 | $154.00K 10-Q · filed 2017-08-14 | |||||
| 2016-12-31 | $611.00 derived: 10-K 12 month − 8-K 9 month · filed 2018-04-02 | $676.00K 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | $675.39K 8-K · filed 2017-02-06 | $761.70K 10-Q · filed 2016-11-03 | ||||
| 2015-12-31 | $3.83M 10-K · filed 2016-03-15 | |||||
| 2014-12-31 | $186.00K 8-K · filed 2017-02-06 | $1.65M 10-K · filed 2015-03-13 | ||||
| 2013-12-31 | $2.32M 10-K · filed 2016-03-15 | |||||
| 2012-12-31 | $2.66M 10-K · filed 2015-03-13 | |||||
| 2011-12-31 | $3.10M 10-K · filed 2014-03-13 | |||||
| 2010-12-31 | $3.70M 10-K · filed 2013-03-21 | |||||
| 2009-12-31 | $4.05M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |